Amh Equity LTD Scynexis Inc Transaction History
Amh Equity LTD
- $70.6 Million
- Q3 2025
A detailed history of Amh Equity LTD transactions in Scynexis Inc stock. As of the latest transaction made, Amh Equity LTD holds 245,939 shares of SCYX stock, worth $145,104. This represents 0.29% of its overall portfolio holdings.
Number of Shares
245,939
Previous 261,081
5.8%
Holding current value
$145,104
Previous $174,000
17.24%
% of portfolio
0.29%
Previous 0.24%
Shares
10 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...